TYRX, INC.

Profile

Company Names

TYRX, INC.
TYRX PHARMA INC

Addresses

1 DEER PARK DRIVE, SUITE G, MONMOUTH JUNCTION, NJ 08852

Phone Numbers

732-246-8676

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$40,669,411.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2013-05-09 
$1,999,999.00 
$1,999,999.00 
$0.00 
Equity 
4
2012-12-20 
$2,034,821.00 
$2,106,000.00 
$71,179.00 
Debt 
3
2012-01-27 
$2,500,000.00 
$5,201,340.00 
$2,701,340.00 
Debt 
2
2010-11-23 
$23,134,591.00 
$25,169,698.00 
$2,035,107.00 
Equity 
1
2009-07-27 
$11,000,000.00 
$11,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EDWARD 
 
CAHILL 
DIRECTOR
SENSABLE TECHNOLOGIES INC   |  PHREESIA, INC.   |  TYRX PHARMA INC   |  TYRX, INC.   |  SPECIAL SITUATIONS SOCIAL MEDIA FUND LLC   |  GEDESCO FUNDING NO. 1 SA   |  IHM SERVICES CO   |  ACP SPECIAL OPPORTUNITY FUND LLC   |  DIRECT VET MARKETING, INC.   |  PERSIVIA HOLDINGS INC.   |  BF RIO HOLDINGS, INC.   |  PERSIVIA INC.
CHARLES 
 
CAHN 
DIRECTOR
TYRX PHARMA INC
WILLIAM 
G. 
DEMPSEY 
DIRECTOR
TYRX PHARMA INC   |  TYRX, INC.
WILLIAM 
 
EDELMAN 
EXECUTIVE OFFICER, DIRECTOR
TYRX PHARMA INC   |  VITATHREADS, LLC   |  MINDCHILD MEDICAL, INC   |  HIGHLAND INSTRUMENTS, INC.
MICHAEL 
T. 
HEFFERNAN 
DIRECTOR
TYRX PHARMA INC   |  TYRX, INC.
MIKE 
 
HEFFERNAN 
DIRECTOR
TYRX PHARMA INC
RAY 
 
IMP 
EXECUTIVE OFFICER
TYRX PHARMA INC   |  TYRX, INC.
JEFF 
 
LEIDEN 
DIRECTOR
TYRX PHARMA INC   |  BIOLEX THERAPEUTICS, INC.   |  PATHAI, INC.
JEFFREY 
 
LEIDEN 
DIRECTOR
LYCERA CORP   |  CATABASIS PHARMACEUTICALS INC   |  TYRX PHARMA INC   |  BIOLEX THERAPEUTICS, INC.   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  CASANA CARE, INC.   |  ODYSSEY THERAPEUTICS, INC.
ARIKHA 
 
MOSES 
EXECUTIVE OFFICER
TYRX PHARMA INC   |  MELODI HEALTH, INC.
ARTHUR 
 
PAPPAS 
DIRECTOR
CENERX BIOPHARMA INC   |  LEAD THERAPEUTICS, INC.   |  TYRX PHARMA INC   |  AFFERENT PHARMACEUTICALS, INC.   |  TYRX, INC.   |  BRAINCELLS INC   |  ASIA INNOVATION VENTURES, LP
SCOTT 
 
REQUADT 
DIRECTOR
TYRX PHARMA INC   |  TYRX, INC.   |  CLARUS DEFINED EXIT I, L.P.   |  CLARUS DE II, L.P.   |  ESSA PHARMA INC.   |  AVROBIO, INC.   |  VBI VACCINES INC/BC   |  CLARUS IV-D, L.P.   |  CLARUS IV-C, L.P.   |  CLARUS IV-B, L.P.   |  CLARUS IV-A, L.P.   |  TALARIS THERAPEUTICS, INC.
ROBERT 
S. 
WHITE 
EXECUTIVE OFFICER, DIRECTOR
TYRX PHARMA INC   |  TYRX, INC.   |  ENTELLUS MEDICAL INC
WILLIAM 
 
YOUNG 
DIRECTOR
COLONIA ENERGY CORP.   |  RENEGADE PETROLEUM LTD.   |  TYRX, INC.   |  CANYON BANCORPORATION   |  ANNEXON, INC.   |  PRAXIS PRECISION MEDICINES, INC.   |  SANA BENEFITS, INC.   |  SATELLITE BIOSCIENCES, INC.   |  COMMUNITY BANCORP OF THE BERKSHIRES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-05-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-09 
2013-01-02
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-20 
2012-02-10
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-01-27 
2010-12-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-23 
2009-08-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2009-07-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#